Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Eplerenone

A selective mineralocorticoid receptor antagonist that blocks the action of aldosterone, approved in the United States in 2002 for hypertension and later also for heart failure after a heart attack. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It was developed as a more selective version of spironolactone: unlike the older drug, it has very little affinity for androgen, progesterone and glucocorticoid receptors.

EplerenoneGo to the active ingredient →
EplerenoneActive ingredientEplerenoneCat. No. P-E070-001CAS 107724-20-9

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceEplerenone CRSEDQM code Y0001704Family Eplerenone

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.